Primo Nutraceuticals Inc. (BUGVF) Stock Analysis
DELISTED 2025
What happened to Primo Nutraceuticals Inc. (BUGVF) stock?
Primo Nutraceuticals Inc. (BUGVF) no longer trades on public markets. It was delisted in January 2025. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Primo Nutraceuticals Inc. (BUGVF) trades at $0.000001. Primo Nutraceuticals Inc. focuses on owning and developing commercial real estate for the cannabis cultivation sector in Canada. Sector: Healthcare.
Last analyzed: Mar 17, 2026Analyst Coverage for BUGVF: BUGVF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BUGVF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
BUGVF: 1/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Primo Nutraceuticals Inc. (BUGVF) Healthcare & Pipeline Overview
Primo Nutraceuticals Inc., operating in the healthcare sector, specializes in developing commercial real estate for cannabis cultivation in Canada. The company offers turnkey facilities and infrastructure to cannabis growers and processors, with additional hemp projects in Oregon and Washington, positioning itself within the specialty and generic drug manufacturing industry.
What Is the Investment Thesis for BUGVF?
Primo Nutraceuticals Inc. presents a speculative investment opportunity within the cannabis sector, focusing on real estate development for cultivation. The company's strategy of providing turnkey facilities could attract cannabis growers seeking operational efficiency. However, the company's financials indicate a lack of profitability, with a negative P/E ratio. The market capitalization is also effectively zero, reflecting the high-risk nature of the investment. Growth catalysts depend on the expansion of the cannabis market in Canada and the successful operation of its U.S. hemp and greenhouse projects. The beta of 1.08 suggests volatility in line with the market. The absence of dividends indicates a focus on reinvesting earnings for growth, though this is speculative given the current financial state.
Based on FMP financials and quantitative analysis
BUGVF Key Highlights
Market Cap of $0.00B indicates the company is a microcap or nano-cap stock with limited liquidity and higher risk.
- P/E Ratio of -0.00 suggests the company is not currently profitable.
- Beta of 1.08 indicates the stock's price is slightly more volatile than the overall market.
- No Dividend Yield implies the company is not returning profits to shareholders, typical for growth-focused or financially distressed companies.
- Focus on cannabis cultivation real estate positions the company in a high-growth but also highly regulated and competitive market.
Who Are BUGVF's Competitors?
BUGVF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BUGVF's Key Strengths?
Specialized focus on cannabis cultivation real estate.
- Turnkey facilities offer convenience to growers.
- Presence in key cannabis markets (Canada, Oregon, Washington).
- Early mover advantage in developing cannabis infrastructure.
What Are BUGVF's Weaknesses?
Limited financial resources.
- Dependence on the cannabis industry's regulatory environment.
- Small market capitalization and limited liquidity.
- Lack of profitability.
What Could Drive BUGVF Stock Higher?
Expansion of cannabis legalization in North America, driving demand for cultivation facilities.
- Development of U.S. hemp and greenhouse projects, generating new revenue streams.
- Strategic partnerships with cannabis growers, securing long-term leases.
- Potential acquisitions of complementary businesses, enhancing capabilities.
- Potential for positive regulatory changes in the cannabis industry.
What Are the Key Risks for BUGVF?
Financial-distress signal — its Altman Z-Score of -5.70 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Intense competition from established cannabis companies.
- Changing regulatory landscape impacting cannabis operations.
- Fluctuations in cannabis prices affecting profitability.
- Economic downturn reducing demand for cannabis products.
- Limited access to capital for expansion and development.
What Are the Growth Opportunities for BUGVF?
- Expansion of Canadian Operations: Primo Nutraceuticals can expand its portfolio of commercial real estate properties for cannabis cultivation in Canada. As the Canadian cannabis market matures, there will be increased demand for specialized cultivation facilities. The company can capitalize on this trend by acquiring or developing new properties in strategic locations, offering customized solutions to cannabis growers. The Canadian cannabis market is projected to reach $4 billion by 2027, providing a significant growth opportunity for Primo Nutraceuticals.
- Development of U.S. Hemp and Greenhouse Projects: Primo Nutraceuticals can further develop its hemp project in Oregon and greenhouse campus in Washington state. The U.S. hemp market is experiencing rapid growth, driven by increasing demand for hemp-derived products such as CBD. The company can leverage its existing assets to cultivate hemp and produce value-added products, targeting the U.S. market. The U.S. hemp market is projected to reach $30 billion by 2028, presenting a substantial growth opportunity.
- Strategic Partnerships with Cannabis Growers: Primo Nutraceuticals can form strategic partnerships with cannabis growers to secure long-term leases and revenue streams. By collaborating with established cannabis companies, the company can ensure a steady demand for its cultivation facilities and benefit from the expertise of its partners. These partnerships can also provide access to new markets and technologies, enhancing Primo Nutraceuticals' competitive advantage. The timeline for establishing these partnerships is ongoing, with potential deals emerging as the cannabis industry consolidates.
- Diversification into Cannabis Processing and Manufacturing: Primo Nutraceuticals can diversify its operations into cannabis processing and manufacturing. By expanding its value chain, the company can capture a larger share of the cannabis market and reduce its reliance on cultivation alone. This diversification can involve establishing processing facilities to extract cannabinoids from cannabis plants and manufacturing cannabis-infused products such as edibles and topicals. The market for cannabis-infused products is growing rapidly, offering a significant growth opportunity for Primo Nutraceuticals.
- Acquisition of Complementary Businesses: Primo Nutraceuticals can pursue strategic acquisitions of complementary businesses in the cannabis industry. This can include acquiring companies that specialize in cannabis cultivation technology, cannabis processing equipment, or cannabis distribution. These acquisitions can enhance Primo Nutraceuticals' capabilities, expand its market reach, and create synergies across its operations. The timeline for these acquisitions depends on market conditions and the availability of suitable targets, but the company can actively explore potential deals to accelerate its growth.
What Are BUGVF's Competitive Advantages?
- Specialized real estate for cannabis cultivation.
- Turnkey facilities reduce barriers to entry for cannabis growers.
- Strategic locations in key cannabis markets (Canada, Oregon, Washington).
- Early mover advantage in developing cannabis cultivation infrastructure.
What Does BUGVF Do?
Primo Nutraceuticals Inc., established in 2014 and based in Vancouver, Canada, operates within the burgeoning cannabis industry. Originally incorporated as Bougainville Ventures Inc., the company rebranded in October 2019 to reflect its focus on nutraceuticals and cannabis-related ventures. Primo Nutraceuticals specializes in owning and developing commercial real estate properties tailored for cannabis cultivation. Its core business model revolves around providing comprehensive, ready-to-use facilities equipped with essential infrastructure for cannabis growers and processors, primarily in Canada. These turnkey facilities are designed to streamline operations for cultivators, offering a hassle-free entry into the cannabis market. Beyond its Canadian operations, Primo Nutraceuticals also owns a hemp project in Oregon and a greenhouse campus in Washington state, expanding its reach into the U.S. cannabis and hemp markets. The company aims to capitalize on the increasing demand for specialized cultivation spaces as the cannabis industry matures and regulatory landscapes evolve.
What Products and Services Does BUGVF Offer?
- Owns and develops commercial real estate for cannabis cultivation.
- Offers turnkey facilities equipped with infrastructure for cannabis growers.
- Provides infrastructure solutions to cannabis processors.
- Owns a hemp project in Oregon.
- Owns a greenhouse campus in Washington state.
- Focuses on the Canadian cannabis market.
How Does BUGVF Make Money?
- Generates revenue through leasing commercial real estate to cannabis growers and processors.
- Develops and equips facilities with necessary infrastructure.
- Potentially generates revenue from hemp cultivation and processing in Oregon.
- Potentially generates revenue from greenhouse operations in Washington.
What Industry Does BUGVF Operate In?
Primo Nutraceuticals Inc. operates in the cannabis industry, which is experiencing rapid growth and evolving regulatory landscapes. The market is characterized by increasing demand for cannabis and cannabis-derived products, driving the need for specialized cultivation facilities. Competition is intense, with numerous players vying for market share, including established cannabis companies and new entrants. Primo Nutraceuticals aims to differentiate itself by providing turnkey real estate solutions for cannabis cultivation, targeting growers seeking efficient and compliant facilities. The company's success depends on its ability to navigate regulatory complexities, secure financing, and establish strong relationships with cannabis growers.
Who Are BUGVF's Key Customers?
- Licensed cannabis growers in Canada.
- Cannabis processors in Canada.
- Hemp cultivators in Oregon.
- Greenhouse operators in Washington.
Company Profile
Primo Nutraceuticals Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Richard Cindric. BUGVF has traded publicly since 2019.
Financial Health
Primo Nutraceuticals Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -5.70 places it in the distress zone, a signal of elevated financial risk.
BUGVF Financials
Bull Case vs Bear Case
Bull Case
- Specialized focus on cannabis cultivation real estate.
- Turnkey facilities offer convenience to growers.
- Presence in key cannabis markets (Canada, Oregon, Washington).
- Early mover advantage in developing cannabis infrastructure.
Bear Case
- Limited financial resources.
- Dependence on the cannabis industry's regulatory environment.
- Small market capitalization and limited liquidity.
- Lack of profitability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
BUGVF Latest News
No recent news available for BUGVF.
Leadership: Richard Cindric
CEO
Information on Richard Cindric's background is not available in the provided data. Further research would be needed to determine his career history, education, and previous roles.
Track Record: Information on Richard Cindric's track record is not available in the provided data. Further research would be needed to determine his key achievements, strategic decisions, and company milestones under his leadership.
BUGVF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Primo Nutraceuticals Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial reporting, making it difficult for investors to assess their financial health and performance. Investing in OTC Other stocks carries significant risks due to the lack of transparency and regulatory oversight compared to stocks listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited or no financial disclosure.
- Low trading volume and liquidity.
- Higher risk of fraud and manipulation.
- Lack of regulatory oversight.
- Potential for delisting or suspension of trading.
- Verify the company's registration and legal status.
- Review any available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal proceedings against the company.
- Company's incorporation and registration details.
- Any available financial statements, even if limited.
- Information on the management team and their experience.
- Existence of a business plan and operational activities.
- Any news or press releases about the company.
BUGVF Healthcare Stock FAQ
What happened to Primo Nutraceuticals Inc. (BUGVF) stock?
Primo Nutraceuticals Inc. (BUGVF) no longer trades on public markets. It was delisted in January 2025. The figures below are historical and are not a current quote.
Can I still buy BUGVF shares?
No. BUGVF stopped trading on public markets in January 2025, so the shares are not available through a broker. Anything you see quoted for BUGVF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BUGVF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Primo Nutraceuticals Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Primo Nutraceuticals Inc. do?
Primo Nutraceuticals Inc. specializes in owning and developing commercial real estate properties for the cannabis cultivation sector, primarily in Canada. The company offers turnkey facilities equipped with essential infrastructure to cannabis growers and processors, streamlining their operations. Additionally, Primo Nutraceuticals owns a hemp project in Oregon and a greenhouse campus in Washington, expanding its reach into the U.S.
What do analysts say about BUGVF stock?
There is currently no available analyst coverage or consensus on BUGVF stock. Given its OTC Other listing and limited financial disclosure, it is unlikely that major brokerage firms provide research reports or ratings. Investors should conduct their own due diligence and consider the risks associated with investing in a microcap stock with limited liquidity and transparency.
What are the main risks for BUGVF?
The main risks for Primo Nutraceuticals Inc. include its limited financial resources, dependence on the evolving regulatory environment of the cannabis industry, small market capitalization, and lack of profitability. As an OTC Other stock, BUGVF faces additional risks related to limited financial disclosure, low trading volume, and potential for fraud and manipulation.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on limited data available for Primo Nutraceuticals Inc.
- OTC stocks carry higher risks than exchange-listed stocks.
- Financial data may not be current or accurate.